Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly
Status:
TERMINATED
Trial end date:
2024-09-19
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to primarily evaluate the efficacy of AVTR101 to placebo on physical performance in sarcopenia patients.
Participants will:
Take AVTR101 or a placebo three times daily for 12 weeks Visit the clinic once every 4 weeks for checkups and tests
Phase:
PHASE2
Details
Lead Sponsor:
Aventi Biotechnology Inc.
Collaborators:
Ajou University School of Medicine Asan Medical Center Seoul National University Bundang Hospital SMG-SNU Boramae Medical Center